Wall Street analysts’ outlook for Avalo Therapeutics Inc. (AVTX)

Avalo Therapeutics Inc. (NASDAQ: AVTX) stock fell -38.37% on Friday to $0.13 against a previous-day closing price of $0.22. With 113.67 million shares changed hands, the volume of the stock remained heavier than its average volume of 22.13 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $0.1800 whereas the lowest price it dropped to was $0.1292. The 52-week range on AVTX shows that it touched its highest point at $7.00 and its lowest point at $0.08 during that stretch. Beta for the stock currently stands at 1.25.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of AVTX was up-trending over the past week, with a rise of 42.47%, but this was up by 3.35% over a month. Three-month performance dropped to -96.48% while six-month performance fell -94.78%. The stock lost -96.83% in the past year, while it has lost -97.37% so far this year. A look at the trailing 12-month EPS for AVTX yields -2.14 with Next year EPS estimates of -4.62. For the next quarter, that number is -1.10. This implies an EPS growth rate of 56.30% for this year and -12.10% for next year.

Float and Shares Shorts:

At present, 62.87 million AVTX shares are outstanding with a float of 62.62 million shares on hand for trading. On Aug 30, 2023, short shares totaled 0.96 million, which was 4.74% higher than short shares on Jul 30, 2023. In addition to Dr. Garry A. Neil M.D. as the firm’s Chairman, Pres & CEO, Mr. Christopher Ryan Sullivan serves as its CFO & Head of Investor relations.

Institutional Ownership:

Through their ownership of 35.76% of AVTX’s outstanding shares, institutional investors have minority control over the company. Other institutions hold 3.77% of AVTX, in contrast to 11.40% held by mutual funds. Shares owned by individuals account for 1.86%. As the largest shareholder in AVTX with 2.66% of the stake, Nantahala Capital Management LLC holds 556,202 shares worth 556,202. A second-largest stockholder of AVTX, The Vanguard Group, Inc., holds 219,514 shares, controlling over 1.05% of the firm’s shares. BlackRock Fund Advisors is the third largest shareholder in AVTX, holding 122,742 shares or 0.59% stake. With a 0.57% stake in AVTX, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 119,822 shares are owned by the mutual fund manager. The iShares Tr. – Micro Cap ETF, which owns about 0.36% of AVTX stock, is the second-largest Mutual Fund holder. It holds 75,094 shares valued at 7509.0. Vanguard Extended Market Index Fu holds 0.34% of the stake in AVTX, owning 72,041 shares worth 7204.0.

An Overview of Recent Financials:

Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, AVTX reported revenue of $1.03M and operating income of -$11.83M. The EBITDA in the recently reported quarter was -$11.80M and diluted EPS was -$1.38.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for AVTX since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With AVTX analysts setting a high price target of $0.75 and a low target of $0.75, the average target price over the next 12 months is $0.75. Based on these targets, AVTX could surge 476.92% to reach the target high and rise by 476.92% to reach the target low. Reaching the average price target will result in a growth of 476.92% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.

Summary of Insider Activity:

Insiders traded AVTX stock several times over the past three months with 1 Buys and 3 Sells. In these transactions, 2,000 shares were bought while 2,545,404 shares were sold. The number of buy transactions has increased to 35 while that of sell transactions has risen to 3 over the past year. The total number of shares bought during that period was 211,257 while 2,545,404 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *